Tag: FY2021
Pharma sector revenue to remain healthy at 8-11% in FY-2022: ICRA
Minimal impact of Covid-19 on the Indian pharmaceutical industry owing to inelastic demand for drugs coupled with continued supply of APIs/KSM from China, which accounts for 60% of industry requirement......................